Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIAGNODE-B: Diamyd Booster in T1D
NCT05351879Phase 2Completed
- Sponsor
- Linköping University
- Start
- May 2022
- Primary completion
- Aug 2023
- Modality
- Recombinant Proteins and Enzymes, Subcutaneous Immunotherapy, Sublingual Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of Diamyd in type 1 diabetes mellitus (T1D), sponsored by Linköping University. Started May 2022; status: completed.
02
Drugs
Diamyd
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT05351879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05351879.